Methicillin-Resistant Staphylococcus Aureus Screening in Total Joint Arthroplasty: A Worthwhile Endeavor

Journal of Knee Surgery

Volumn 25, Issue 1, 2011, Pages 37-44

  Goyal, Nitin ^a   Aggarwal, Vinay ^a   Parvizi, Javad ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Joint arthroplasty; Methicillin Resistant Staphylococcus aureus; Orthopedic surgery; Surgical site infection

Indexed keywords

ANTIINFECTIVE AGENT; PSEUDOMONIC ACID;

ARTHROPLASTY; ARTICLE; HUMAN; INFECTION; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MUPIROCIN; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

EID: 84862266644     PISSN: 15388506     EISSN: 19382480     Source Type: Journal    
DOI: 10.1055/s-0031-1286194     Document Type: Article

References (67)

1. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32(8): 470-485
2. Schaberg D.R. Resistant gram-positive organisms. Ann Emerg Med 1994; 24(3): 462-464
3. Hidron AI, Edwards JR, Patel J, et al; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29(11): 996-1011
4. Moran GJ, Amii RN, Abrahamian FM, Talan D.A. Methicillin-resis-tant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 2005; 11(6): 928-930
5. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008; 197(9): 1226-1234
6. Barber M. Methicillin-resistant staphylococci. J Clin Pathol 1961; 14: 385-393
7. Benner EJ, Kayser F.H. Growing clinical significance of methcillin-resistant Staphylococcus aureus. Lancet 1968; 2(7571): 741-744
8. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39(3): 309-317
9. Schwarzkopf R, Takemoto RC, Immerman I, Slover JD, Bosco J.A. Prevalence of Staphylococcus aureus colonization in orthopaedic surgeons and their patients: a prospective cohort controlled study. J Bone Joint Surg Am 2010; 92(9): 1815-1819
10. Kenner J, O'Connor T, Piantanida N, et al. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 2003; 24(6): 439-444
11. Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis 2008; 8(5): 289-301
12. Deleo FR, Otto M, Kreiswirth BN, Chambers H.F. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010; 375(9725): 1557-1568
13. Giannoudis PV, Parker J, Wilcox M.H. Methicillin-resistant Staphylococcus aureus in trauma and orthopaedic practice. J Bone Joint Surg Br 2005; 87(6): 749-754
14. Patel A, Calfee RP, Plante M, Fischer SA, Arcand N, Born C. Methicillin-resistant Staphylococcus aureus in orthopaedic surgery. J Bone Joint Surg Br 2008; 90(11): 1401-1406
15. Graham PL III, Lin SX, Larson E.L. U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med 2006; 144(5): 318-325
16. Rozgonyi F, Kocsis E, Kristóf K, Nagy K. Is MRSA more virulent than MSSA? Clin Microbiol Infect 2007; 13(9): 843-845
17. Wang R, Braughton KR, Kretschmer D, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007; 13(12): 1510-1514
18. Kobayashi SD, DeLeo F.R. An update on community-associated MRSA virulence. Curr Opin Pharmacol 2009; 9(5): 545-551
19. Fridkin SK, Hageman JC, Morrison M, et al; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352(14): 1436-1444
20. Haley RW, Culver DH, White JW, Morgan WM, Emori T.G. The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol 1985; 121(2): 159-167
21. Lee J, Singletary R, Schmader K, Anderson DJ, Bolognesi M, Kaye K. S. Surgical site infection in the elderly following orthopaedic surgery. Risk factors and outcomes. J Bone Joint Surg Am 2006; 88(8): 1705-1712
22. Prokuski L. Prophylactic antibiotics in orthopaedic surgery. J Am Acad Orthop Surg 2008; 16(5): 283-293
23. Price CS, Williams A, Philips G, Dayton M, Smith W, Morgan S. Staphylococcus aureus nasal colonization in preoperative orthopaedic outpatients. Clin Orthop Relat Res 2008; 466(11): 2842-2847
24. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control 1998; 26(5): 522-533
25. Zimmerli W, Trampuz A, Ochsner P.E. Prosthetic-joint infections. N EnglJ Med 2004; 351(16): 1645-1654
26. Widmer A.F. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 2001 ; 33(Supplement 2): S94-S106
27. Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998; 27 (5): 1247-1254
28. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008; 23(7): 984-991
29. Florman S, Nichols R.L. Current Approaches for the Prevention of Surgical Site Infections. Am J Infect Dis 2007; 3(1): 51-61
30. Blumberg H.M. Community-acquired versus healthcare-associated methicillin-resistant (MRSA) infections: is the distinction blurring? Clinical Updates in Infections Disease 2009; 12(1): 1-6
31. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton D.J. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002; 23(4): 183-189
32. Hanssen AD, Trousdale RT, Osmon D.R. Patient outcome with reinfection following reimplantation for the infected total knee arthroplasty. Clin Orthop Relat Res 1995; 321(321): 55-67
33. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003; 36(5): 592-598
34. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis 2003; 9 (2): 196-203
35. Hofmann AA, Kane KR, Tkach TK, Plaster RL, Camargo M.P. Treatment of infected total knee arthroplasty using an articulating spacer. Clin Orthop Relat Res 1995; 321(321): 45-54
36. Berbari EF, Osmon DR, Duffy MC, et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 2006; 42(2): 216-223
37. Mittal Y, Fehring TK, Hanssen A, Marculescu C, Odum SM, Osmon D. Two-stage reimplantation for periprosthetic knee infection involving resistant organisms. J Bone Joint Surg Am 2007; 89 (6): 1227-1231
38. Mont MA, Waldman BJ, Hungerford D.S. Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection. A comparison-group study. J Bone Joint Surg Am 2000; 82-A(11): 1552-1557
39. Bratzler DW, Houck PM; Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005; 189(4): 395-404
40. Hill DA, Herford T, Parratt D. Antibiotic usage and methicillin-resistant Staphylococcus aureus: an analysis of causality. J Antimicrob Chemother 1998; 42(5): 676-677
41. Marcotte AL, Trzeciak M.A. Community-acquired methicillin-resis-tant Staphylococcus aureus: an emerging pathogen in orthopaedics. J Am Acad Orthop Surg 2008; 16(2): 98-106
42. Dowsey MM, Choong P.F. Early outcomes and complications following joint arthroplasty in obese patients: a review of the published reports. ANZ J Surg 2008; 78(6): 439-444
43. American Academy of Orthopaedic Surgeons Patient Safety Committee. Evans RP. Surgical site infection prevention and control: an emerging paradigm. J Bone Joint Surg Am 2009; 91 (Supplement 6): 2-9
44. Malinzak RA, Ritter M.A. Postoperative wound infection: 35 years of experience. Orthopedics 2006; 29(9): 797-798
45. Tobin E.H. Prosthetic joint infections: controversies and clues. Lancet 1999; 353(9155): 770-771
46. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, de Baere GA. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000; 21(5): 319-323
47. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10(3): 505-520
48. Paule SM, Pasquariello AC, Hacek DM, et al. Direct detection of Staphylococcus aureus from adult and neonate nasal swab specimens using real-time polymerase chain reaction. J Mol Diagn 2004; 6(3): 191-196
49. Tacconelli E, De Angelis G, de Waure C, Cataldo MA, La Torre G, Cauda R. Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and metaanalysis. Lancet Infect Dis 2009; 9(9): 546-554
50. Safdar N, Bradley E.A. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 2008; 121(4): 310-315
51. Garrouste-Orgeas M, Timsit JF, Kallel H, et al. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use. Infect Control Hosp Epidemiol 2001; 22(11): 687-692
52. Yano K, Minoda Y, Sakawa A, et al. Positive nasal culture of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site infection in orthopedics. Acta Orthop 2009; 80 (4): 486-490
53. Kim DH, Spencer M, Davidson SM, et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am 2010; 92(9): 1820-1826
54. Pofahl WE, Goettler CE, Ramsey KM, Cochran MK, Nobles DL, Rotondo M.F. Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA. J Am Coll Surg 2009; 208(5): 981-986, discussion 986-988
55. Muder RR, Brennen C, Wagener MM, et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991; 114(2): 107-112
56. von Eiff C, Becker K, Machka K, Stammer H, Peters G; Study Group. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344(1): 11-16
57. Perl TM, Golub J.E. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann Pharmacother 1998; 32(1): S7-S16
58. Wertheim HF, Vos MC, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus noncarriers. Lancet 2004; 364(9435): 703-705
59. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002; 35(4): 353-358
60. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43(6): 1412-1416
61. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362(1): 9-17
62. Darouiche RO, Wall MJ Jr, Itani KM, et al. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med 2010; 362(1): 18-26
63. Wilcox MH, Hall J, Pike H, et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003; 54(3): 196-201
64. Nicholson MR, Huesman L.A. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am J Infect Control 2006; 34(1): 44-48
65. Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP, Peterson L.R. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res 2008; 466(6): 1349-1355
66. Gilpin DF, Small S, Bakkshi S, Kearney MP, Cardwell C, Tunney M.M. Efficacy of a standard methicillin-resistant Staphylococcus aureus decolonisation protocol in routine clinical practice. J Hosp Infect 2010; 75(2): 93-98
67. Otto M. Looking toward basic science for potential drug discovery targets against community-associated MRSA. Med Res Rev 2010; 30(1): 1-22